BALAXI PHARMACEUTICALS
|
The Current P/E Ratio of BALAXI PHARMACEUTICALS is 10.19.
| Share Price | ₹26.8 | Dec 30,2025 |
| Market Cap | ₹147.8 Cr | |
| Earnings-TTM | ₹14.5 Cr | TTM-Consolidated Results |
| Price/Earnings | 10.19x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of BALAXI PHARMACEUTICALS
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹147.8 Cr] as on Dec 30,2025
(/) Earnings [ ₹14.5 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 10.19x ]
Thus, for BALAXI PHARMACEUTICALS , the investors are currently willing to pay 10.19 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of BALAXI PHARMACEUTICALS !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of BALAXI PHARMACEUTICALS over the last five years.
Historical PE (Price/Earnings) ratio chart of BALAXI PHARMACEUTICALS
PE Ratio Performance Analysis for BALAXI PHARMACEUTICALS
- BALAXI PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 7.25x.
- BALAXI PHARMACEUTICALS 's operated at median p/e ratio of 7.3x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, BALAXI PHARMACEUTICALS 's p/e ratio peaked in Mar2021 at 14.09x.
- BALAXI PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2024 of 0x.
How does BALAXI PHARMACEUTICALS 's P/E Ratio benchmark against top 10 peers in Trading Industry?
| Peer Comparison (Trading Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| BALAXI PHARMACEUTICALS | 14.50 | 10.19 | 147.8 |
| ADANI ENTERPRISES LTD | 8,253.33 | 34.69 | 286,342.0 |
| REDINGTON LTD | 1,903.88 | 11.02 | 20,986.7 |
| MMTC LTD | 170.02 | 59.54 | 10,123.5 |
| HONASA CONSUMER LTD | 131.56 | 72.05 | 9,478.0 |
| LLOYDS ENTERPRISES LTD | 355.27 | 25.85 | 9,182.2 |
| ENTERO HEALTHCARE SOLUTIONS LTD | 127.70 | 32.36 | 4,132.7 |
| OPTIEMUS INFRACOM LTD | 67.86 | 64.57 | 4,381.7 |
| POLO QUEEN INDUSTRIAL & FINTECH LTD | 2.70 | 382.95 | 1,032.4 |
| MSTC LTD | 423.03 | 8.56 | 3,622.1 |
| SG MART LTD | 120.03 | 39.90 | 4,788.6 |
Trading Industry Benchmark (Top 10) PE Analysis vs BALAXI PHARMACEUTICALS 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 8.56x |
| Max industry PE | 382.95x |
| Median industry PE | 34.69x |
| Average industry PE | 67.43x |
You may also like the below Video Courses